Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Replaced the location name Padua with Padova for the Italy site (Padova, 35128) to reflect the official local naming.
    Difference
    0.0%
    Check dated 2026-04-05T19:35:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Naples, Italy (80131) was added as a study site and Napoli, Italy (80131) was removed, with the city name updated to Naples and the revision upgraded from 3.4.3 to 3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T09:24:31.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision history updated to v3.4.3 with new dates (2026-03-04, 2026-02-12, 2026-02). Previous revision v3.4.2 is superseded.
    Difference
    0.1%
    Check dated 2026-03-08T02:07:43.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added: Revision: v3.4.2; Deleted: Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T12:57:27.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    This change is a minor revision updating the page from v3.4.0 to v3.4.1 with no visible impact on study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T07:13:04.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Minor UI and labeling updates: glossary display is now shown by default, a 'Last Update Submitted that Met QC Criteria' indicator was added, the FEAR Act data label capitalization changed, and the page revision updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T05:12:58.000Z thumbnail image

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.